CA4576376012 - Common Stock
INMED PHARMACEUTICALS INC
NASDAQ:INM (5/6/2024, 7:07:39 PM)
After market: 0.2599 +0 (+1.6%)0.2558
+0.01 (+5.7%)
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-06-21. The firm is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.
INMED PHARMACEUTICALS INC
Suite 310, 815 W. Hastings Street
Vancouver BRITISH COLUMBIA V6C1B4
P: 16046697207
CEO: Eric Adams
Employees: 0
Website: https://www.inmedpharma.com/
Get insights into the top gainers and losers of Thursday's pre-market session.
Get insights into the top gainers and losers of Wednesday's after-hours session.
InMed Pharmaceuticals (INM) Friday announced the appointment of Netta Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20. Jagpal j
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
InMed Pharmaceuticals files prospectus for resale of 12.57M shares by selling shareholders, not an offer to sell securities.
Here you can normally see the latest stock twits on INM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: